International Clinical Trial: Study on the mechanism and molecular imaging of the effect of abnormal brain glymphatic function on abnormal deposition of TDP-43 and promoting the progression of AD and ALS

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132254) titled 'Study on the mechanism and molecular imaging of the effect of abnormal brain glymphatic function on abnormal deposition of TDP-43 and promoting the progression of AD and ALS' on Sept. 11.

Study Type: Observational study

Study Design: Diagnostic test for accuracy

Primary Sponsor: Huashan Hospital, Fudan University

Condition: Amyotrophic Lateral Sclerosis, Alzheimer's disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-11

Target Sample Size: The group with abnormal brain lymph function:9;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.c...